D-0435-2017 Class III Terminated
FDA drug recall D-0435-2017 was initiated by Sandoz Inc on Dec 13, 2016 and is designated Class III. Reason for recall: Subpotent Drug: out of specification results for assay test. The recall status is terminated (terminated Sep 14, 2017). Affected quantity: a) 10,200 bottles; b) 300 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 25, 2017
- Initiation Date
- Dec 13, 2016
- Termination Date
- Sep 14, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 10,200 bottles; b) 300 bottles
Product description
Donepezil Hydrochloride Tablets, 10 mg, packaged in a) 30-count bottles (NDC 0781-5275-31) and b) 1000-count bottles (NDC 0781-5275-10), Rx only, Manufactured in India by Sandoz Private Ltd for Sandoz Inc., Princeton, NJ 08540.
Reason for recall
Subpotent Drug: out of specification results for assay test.
Distribution pattern
Nationwide in the USA
Code information
Lot #: a) FJ6599, Exp 05/17 and b) FJ6600, Exp 05/17
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0435-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026